Stylianos Panopoulos

Cardiac Tissue Characterization and the Diagnostic Value of Cardiovascular Magnetic Resonance in Systemic Connective Tissue Diseases

Sophie Mavrogeni, Petros P. Sfikakis, Elias Gialafos et al. · Arthritis Care & Research · 2013 · 77 citations

Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study

Antonis Fanouriakis, Christina Adamichou, Sofia Koutsoviti et al. · Seminars in Arthritis and Rheumatism · 2018 · 77 citations

Autoimmune Disease, Systemic Lupus Erythematosus, Systemic Lupus Erythematosus Treatment +8

Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases

Charalampos Papagoras, G. Fragoulis, Nikoleta Zioga et al. · Annals of the Rheumatic Diseases · 2021 · 67 citations

Mycophenolate Versus Cyclophosphamide for Progressive Interstitial Lung Disease Associated with Systemic Sclerosis: A 2-Year Case Control Study

Stylianos Panopoulos, Vassiliki-Kalliopi Bournia, Georgia Trakada et al. · Lung · 2013 · 65 citations

Autoimmune Disease, Inflammatory Lung Disease, Advanced Lung Disease +6

The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial

George Karamanolis, Stylianos Panopoulos, Konstantinos Denaxas et al. · Arthritis Research & Therapy · 2016 · 53 citations · Full text